3 Results for "

HM43239

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "HM43239" in MCE Product Catalog:

Cat. No.: HY-145015
CAS No.: 2294874-49-8
Purity:  99.85%
Synonyms: HM43239
Target:  

FLT3 Apoptosis

Research Areas:  

Cancer

Tuspetinib (HM43239) is an orally active and selective FLT3 inhibitor with IC50s of 1.1 nM, 1.8 nM and 1.0 nM for FLT3 WT, FLT3 internal tandem duplication (ITD) and FLT3 D835Y kinases, respectively. Tuspetinib inhibits the kinase activity of FLT3 as a reversible type I inhibitor and modulates p-STAT5, p-ERK, SYK, JAK1/2, and TAK1. Tuspetinib inhibits the proliferation and induces the apoptosis of leukemic cells .
loading...
    loading...
Cat. No.: HY-145015A
CAS No.: 2758339-04-5
Synonyms: HM43239 hydrate
Target:  

FLT3 Apoptosis

Research Areas:  

Cancer

Tuspetinib (HM43239) hydrate is an orally active and selective FLT3 inhibitor with IC50s of 1.1 nM, 1.8 nM and 1.0 nM for FLT3 WT, FLT3 internal tandem duplication (ITD) and FLT3 D835Y kinases, respectively. Tuspetinib hydrate inhibits the kinase activity of FLT3 as a reversible type I inhibitor and modulates p-STAT5, p-ERK, SYK, JAK1/2, and TAK1. Tuspetinib hydrate inhibits the proliferation and induces the apoptosis of leukemic cells .
loading...
    loading...
Cat. No.: HY-145015B
CAS No.: 3037216-20-6
Synonyms: HM43239 dihydrochloride
Target:  

FLT3 Apoptosis

Research Areas:  

Cancer

Tuspetinib (HM43239) dihydrochloride is an orally active and selective FLT3 inhibitor with IC50s of 1.1 nM, 1.8 nM and 1.0 nM for FLT3 WT, FLT3 internal tandem duplication (ITD) and FLT3 D835Y kinases, respectively. Tuspetinib dihydrochloride inhibits the kinase activity of FLT3 as a reversible type I inhibitor and modulates p-STAT5, p-ERK, SYK, JAK1/2, and TAK1. Tuspetinib dihydrochloride inhibits the proliferation and induces the apoptosis of leukemic cells .
loading...
    loading...